Article
Docetaxel HIPEC Combined with Endostar versus Docetaxel HIPEC Alone in Treatment of Malignant Ascites:A Retrospective Study
2021-03-22
Abstract excerpt
<title>Abstract</title> <p><bold>Objective:</bold>The purpose of this study is to retrospectively observe the clinical efficacy and adverse reactions of docetaxel hyperthermic intraperitoneal chemotherapy (HIPEC) combined with endostar in treatment of malignant ascites. <bold>Methods:</bold>56 cases of malignant ascites admitted to Zhejiang Hospital from July 2019 and October 2020 had received no less than second...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e16f679-af52-5ba7-afb6-3a45d3d5b63d
- DOI
- 10.21203/rs.3.rs-306501/v1
